Page 5 - ஜென்னர் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioNTech using COVID jab technology to develop effective malaria vaccine Tuesday 27th July 2021 04:45 BST BioNTech, who developed the first coronavirus jab with US company Pfizer, is aiming to begin clinical trials for a safe and highly effective malaria vaccine by the end of next year. According to the World Health Organisation (WHO), there were an estimated 229 million cases of malaria globally in 2019, with about 409,000 deaths that year. The WHO estimates that children under five accounted for 67% of deaths in 2019 and 94% of cases and deaths were in Africa. Biotech s chief executive Ugur Sahin said: We are already working on HIV and tuberculosis, and malaria is the third big indication (disease) with a high unmet medical need.

Prakash srinivasanUgur sahinResearchers at oxford jenner instituteJohns hopkins bloomberg school of public healthWorld health organisationJohns hopkins bloomberg schoolJenner instituteஆராய்ச்சியாளர்கள் இல் ஆக்ஸ்ஃபர்ட் ஜென்னர் நிறுவனம்ஜான்ஸ் ஹாப்கின்ஸ் ப்ளூம்பெர்க் பள்ளி ஆஃப் பொது ஆரோக்கியம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்ஜான்ஸ் ஹாப்கின்ஸ் ப்ளூம்பெர்க் பள்ளிஜென்னர் நிறுவனம்